{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:27:24Z","timestamp":1793197644141,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10181-x","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T10:58:01Z","timestamp":1731322681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tuberculosis treatment outcome of TB\/HIV co-infected patients at Adare Hospital, Hawassa City Administration, Sidama Region"],"prefix":"10.1186","volume":"24","author":[{"given":"Endrias Markos","family":"Woldesemayat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taye","family":"Gari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"10181_CR1","unstructured":"WHO. Global tuberculosis report. In. Jeneva, Switzerlands; 2022."},{"key":"10181_CR2","volume-title":"Harrison\u2019s principles of internal medicine","author":"DL Kasper","year":"2015","unstructured":"Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscalzo J. Harrison\u2019s principles of internal medicine. 19th ed. New York: McGraw-Hill Education; 2015.","edition":"19"},{"key":"10181_CR3","unstructured":"Luetkemeyer A, Tuberculosis. and HIV. HIV In Site Knowledge Base Chapter. http:\/\/hivinsite.ucsf.edu\/"},{"key":"10181_CR4","unstructured":"WHO. Global tuberculosis report. In. Geneva, Switzerlands; 2020."},{"key":"10181_CR5","unstructured":"UNAIDS|WHO policy statement on HIV testing. WHO|HTM|TB|2004, 330. http:\/\/www.who.int\/hiv\/topics\/tb\/actions\/en\/"},{"key":"10181_CR6","unstructured":"University of California San Francisco. Comprehensive, up-to-date information on HIV\/AIDS treatment, prevention, and policy. 2013. http:\/\/hivinsite.ucsf.edu\/InSite?page=kb-05-01-06"},{"key":"10181_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1186\/s12879-016-1967-3","volume":"16","author":"AA Solomon","year":"2016","unstructured":"Solomon AA, Thandisizwe RM, Ribka F, Tadesse A. Outcomes of TB treatment in HIVco-infected TB patients in Ethiopia. BMC Infect Dis. 2016;16:640.","journal-title":"BMC Infect Dis"},{"key":"10181_CR8","unstructured":"MOH. Implementation Guideline for TB\/HIV collaborative activities in Ethiopia. 4th ed. Addis Ababa; 2008."},{"key":"10181_CR9","unstructured":"WHO. Global tuberculosis report. In. Geneva, Switherlands; 2019."},{"issue":"2","key":"10181_CR10","first-page":"588","volume":"16","author":"AA Mitku","year":"2016","unstructured":"Mitku AA, Dessie ZG, Muluneh EK, Workie DL. Prevalence and associated factors of TB\/HIV co-infection among HIV infected patients in Amhara region, Ethiopia. Afr Health Sci. 2016;16(2):588\u201395.","journal-title":"Afr Health Sci"},{"issue":"3","key":"10181_CR11","first-page":"202","volume":"12","author":"JL Weinberg","year":"2010","unstructured":"Weinberg JL. Kovarik. The WHO Clinical Staging System for HIV\/AIDS. AMA J Ethics Virtual Mentor. 2010;12(3):202\u20136.","journal-title":"AMA J Ethics Virtual Mentor"},{"issue":"12","key":"10181_CR12","doi-asserted-by":"publisher","first-page":"e114225","DOI":"10.1371\/journal.pone.0114225","volume":"9","author":"MH Dangisso","year":"2014","unstructured":"Dangisso MH, Datiko DG, Lindtj\u00f8rn B. Trends of Tuberculosis case notification and treatment outcomes in the Sidama Zone, southern Ethiopia: ten-year retrospective trend analysis in urban-rural settings. PLoS ONE. 2014;9(12):e114225.","journal-title":"PLoS ONE"},{"key":"10181_CR13","unstructured":"https:\/\/www.openepi.com\/SampleSize\/SSCohort.htm"},{"issue":"7","key":"10181_CR14","doi-asserted-by":"publisher","first-page":"e0218800","DOI":"10.1371\/journal.pone.0218800","volume":"14","author":"EA Tanue","year":"2019","unstructured":"Tanue EA, Nsagha DS, Njamen TN, Assob NJC. Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon. PLoS ONE. 2019;14(7):e0218800.","journal-title":"PLoS ONE"},{"key":"10181_CR15","unstructured":"WHO. Definitions and reporting framework for tuberculosis\u20142013 revision, Tech. Rep. WHO\/HTM\/TB\/2013.2, World Health Organization, Geneva, Switzerland, 2013, http:\/\/apps.who.int\/iris\/bitstream\/10665\/79199\/1\/9789241505345_eng.pdf"},{"key":"10181_CR16","doi-asserted-by":"crossref","unstructured":"Moses MN, Mohammed AR, Deche S, Hiram M, Oscar A, Jane K. Burden of HIV and treatment outcomes among TB patients in rural Kenya: a 9\u2013year longitudinal study BMC infectious diseases (2023) 23:362.","DOI":"10.1186\/s12879-023-08347-0"},{"issue":"3","key":"10181_CR17","doi-asserted-by":"publisher","first-page":"e0194675","DOI":"10.1371\/journal.pone.0194675","volume":"13","author":"S Eshetie","year":"2018","unstructured":"Eshetie S, Gizachew M, Alebel A, van Soolingen D. Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: a systematic review and meta-analysis. PLoS ONE. 2018;13(3):e0194675.","journal-title":"PLoS ONE"},{"key":"10181_CR18","doi-asserted-by":"crossref","unstructured":"Yinfa Z, Tao L, Shufang L, Daiquan C, Yongcheng D, Jiangfeng C. Characteristics and treatment outcomes of co-infected tuberculosis patients with human immunodeficiency virus in Southeast China, 2012\u20132021 BMC infectious diseases (2023) 23:528.","DOI":"10.1186\/s12879-023-08501-8"},{"key":"10181_CR19","doi-asserted-by":"crossref","unstructured":"Kenneth MH, Delia AB, Adwoa AP, Ernest K. Predictors of Adverse TB Treatment Outcome among TB\/HIV Patients Compared with Non-HIV Patients in the Greater Accra Regional Hospital from 2008 to 2016. Tuberculosis Research and Treatment Volume 2020, Article ID 1097581.","DOI":"10.1155\/2020\/1097581"},{"key":"10181_CR20","first-page":"206","volume":"32","author":"O Lily","year":"2019","unstructured":"Lily O, Margaret L, Oluwayemisi O, Andrew A, Awewura K, Richard MA. Effect of HIV infection on TB treatment outcomes and time to mortality in two urban hospitals in Ghana-a retrospective cohort study. Pan Afr Med J. 2019;32:206.","journal-title":"Pan Afr Med J"},{"issue":"5","key":"10181_CR21","doi-asserted-by":"publisher","first-page":"e0127024","DOI":"10.1371\/journal.pone.0127024","volume":"10","author":"KB Jacobson","year":"2015","unstructured":"Jacobson KB, Moll AP, Friedland GH, Shenoi SV. Successful tuberculosis treatment outcomes among HIV\/TB Coinfected patients Down- referred from a District Hospital to Primary Health Clinics in Rural South Africa. PLoS ONE. 2015;10(5):e0127024.","journal-title":"PLoS ONE"},{"key":"10181_CR22","doi-asserted-by":"crossref","unstructured":"Fentie AM, Jorgi T, Assefa T. Tuberculosis treatment outcome among patients treated in public primary healthcare facility, Addis Ababa, Ethiopia: a retrospective study. Archives of Public Health volume 78, Article number: 12 (2020).","DOI":"10.1186\/s13690-020-0393-6"},{"issue":"1","key":"10181_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13690-022-00807-4","volume":"80","author":"GK Geoffrey","year":"2022","unstructured":"Geoffrey GK, Moses N, Teresia M, Deche S, Osman AA. Tuberculosis poor treatment outcomes and its determinants in Kilifi County, Kenya: a retrospective cohort study from 2012 to 2019. Arch Public Health. 2022;80(1):48.","journal-title":"Arch Public Health"},{"issue":"12","key":"10181_CR24","doi-asserted-by":"publisher","first-page":"e115211","DOI":"10.1371\/journal.pone.0115211","volume":"9","author":"A Ako","year":"2014","unstructured":"Ako A, Bigna JJR, Billong SC, Tejiokem MC, Ekali JL, Plottel CS. Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaound\u00e9 Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006\u20132013). PLoS ONE. 2014;9(12):e115211.","journal-title":"PLoS ONE"},{"key":"10181_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1471-2334-13-297","volume":"13","author":"B Sileshi","year":"2013","unstructured":"Sileshi B, Deyessa N, Girma B, Melese M. Suarez predictors of mortality among TB-HIV co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study. BMC Infect Dis. 2013;13:297.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10181_CR26","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1071\/HCv10n1_ED1","volume":"10","author":"T Stephane","year":"2018","unstructured":"Stephane T, Gboyega AO, Andre C. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: does cotrimoxazole preventive therapy and\/or antiretroviral therapy protect against death? Afr J Prim Health Care Fam Med. 2018;10(1):e1\u20135.","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"10181_CR27","doi-asserted-by":"publisher","first-page":"100279","DOI":"10.1016\/j.jctube.2021.100279","volume":"25","author":"AA Mikias","year":"2021","unstructured":"Mikias AA, Aman Y, Fikirte G, Fanna A, Kumlachew M, Mengistu B. Impact of HIV-AIDS on Tuberculosis treatment outcome in Southern Ethiopia - A retrospective cohort study. J Clin Tuberc Other Mycobact Dis. 2021;25:100279.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10181_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12879-017-2238-7","volume":"17","author":"S Yenework","year":"2017","unstructured":"Yenework S, Shitaye A, Abel F, Mucheye G, Sinshaw, et al. BMC Infect Dis. 2017;17:132.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10181_CR29","doi-asserted-by":"publisher","first-page":"e0253449","DOI":"10.1371\/journal.pone.0253449","volume":"16","author":"Z Dawit","year":"2021","unstructured":"Dawit Z, Abebe S, Dessu S, Mesele M, Sahile S, Ajema D. Incidence and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at public hospitals in Southern Ethiopia. PLoS ONE. 2021;16(6):e0253449.","journal-title":"PLoS ONE"},{"issue":"8","key":"10181_CR30","doi-asserted-by":"publisher","first-page":"e73250","DOI":"10.1371\/journal.pone.0073250","volume":"8","author":"I Ismail","year":"2013","unstructured":"Ismail I, Bulgiba A. Predictors of death during tuberculosis treatment in TB\/HIV co-infected patients in Malaysia. PLoS ONE. 2013;8(8):e73250.","journal-title":"PLoS ONE"},{"key":"10181_CR31","doi-asserted-by":"crossref","unstructured":"Deribe K, Yami A, Deribew A, Gedlu NM, Colebunders R, Geertruyden JPV. Predictors of mortality among Tuberculosis\/HIV-Coinfected persons in Southwest Ethiopia: a case-control study. 2015. J Int Association Providers AIDS Care 14(3).","DOI":"10.1177\/2325957413500528"},{"key":"10181_CR32","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2147\/IDR.S446020","volume":"17","author":"TW Kegne","year":"2024","unstructured":"Kegne TW, Anteneh ZA, Bayeh TL, Shiferaw BM, Tamiru DH. Survival rate and predictors of Mortality among TB-HIV co-infected patients during tuberculosis treatment at Public Health Facilities in Bahir Dar City, Northwest Ethiopia. Infect Drug Resist. 2024;17:1385\u201395.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10181_CR33","first-page":"52","volume":"18","author":"AN Roya","year":"2013","unstructured":"Roya AN, Ali M, Maliheh M, Mehdi M, Mahnaz Z. Factors associated with mortality in tuberculosis patients. J Res Med Sci. 2013;18(1):52\u20135.","journal-title":"J Res Med Sci"},{"issue":"1","key":"10181_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13690-021-00713-1","volume":"80","author":"J Gemechu","year":"2022","unstructured":"Gemechu J, Gebremichael B, Tesfaye T, Seyum A, Erkalo D. Predictors of mortality among TB-HIV co-infected children attending anti-retroviral therapy clinics of selected public hospitals in southern, Ethiopia: retrospective cohort study. Arch Public Health. 2022;80(1):11.","journal-title":"Arch Public Health"},{"issue":"12","key":"10181_CR35","doi-asserted-by":"publisher","first-page":"e0258964","DOI":"10.1371\/journal.pone.0258964","volume":"16","author":"SC Ermias","year":"2021","unstructured":"Ermias SC, Getnet AG, Tesfaye YT, Dejen GF, Wubet TA, Eshetie MA. Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study. PLoS ONE. 2021;16(12):e0258964.","journal-title":"PLoS ONE"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10181-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10181-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10181-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T12:03:11Z","timestamp":1731326591000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10181-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10181"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10181-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"11 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval to carry out the study was obtained from the Hawassa University College of Medicine and Health Sciences Institutional Review Board (IRB) Reference number IRB 279\/15 on the date 30\/03\/2023. The need for informed consent to participate was also waived by the ethics committee that approved the study. An official letter of support was obtained from the Sidama Region Public Health Institute (SRPHI). Permission was obtained from Adare Hospital. As the study was based on secondary data, no consent was needed to obtain from the study participants including the consent for minors. The IRB has approved the waiver of informed consent to participate in the study. The data collected were anonymous, and the confidentiality of the data was maintained. The data were handled by the researchers only.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1281"}}